Similar articles for PMID: 34732446

Year	Number of Results
1993	1
1995	1
1996	1
1997	1
1998	1
2000	1
2001	1
2005	1
2009	3
2010	2
2013	1
2014	3
2015	12
2016	14
2017	13
2018	17
2019	16
2020	16
2021	9
2022	3
2023	1
2024	0

1

Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia.

Takahashi M, Takahashi K, Kaneda H, Kawaguchi T, Nagayama K. Takahashi M, et al. Anticancer Res. 2021 Nov;41(11):5729-5737. doi: 10.21873/anticanres.15389. Anticancer Res. 2021. PMID: 34732446

2

Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer.

Ikesue H, Watanabe H, Hirano M, Chikamori A, Suetsugu K, Ryokai Y, Egashira N, Yamada T, Ikeda M, Iwama E, Harada T, Takayama K, Nakanishi Y, Masuda S. Ikesue H, et al. Biol Pharm Bull. 2015;38(8):1192-8. doi: 10.1248/bpb.b15-00162. Biol Pharm Bull. 2015. PMID: 26235582 Free article.

3

Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure.

Schmitt A, Gladieff L, Laffont CM, Evrard A, Boyer JC, Lansiaux A, Bobin-Dubigeon C, Etienne-Grimaldi MC, Boisdron-Celle M, Mousseau M, Pinguet F, Floquet A, Billaud EM, Durdux C, Le Guellec C, Mazières J, Lafont T, Ollivier F, Concordet D, Chatelut E. Schmitt A, et al. J Clin Oncol. 2010 Oct 20;28(30):4568-74. doi: 10.1200/JCO.2010.29.3597. Epub 2010 Sep 20. J Clin Oncol. 2010. PMID: 20855828

4

Relationship between prognosis and neutrophil: lymphocyte and platelet:lymphocyte ratios in patients with malignant pleural mesotheliomas.

Cihan YB, Ozturk A, Mutlu H. Cihan YB, et al. Asian Pac J Cancer Prev. 2014;15(5):2061-7. doi: 10.7314/apjcp.2014.15.5.2061. Asian Pac J Cancer Prev. 2014. PMID: 24716935 Free article.

5

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

Langer CJ, Gadgeel SM, Borghaei H, Papadimitrakopoulou VA, Patnaik A, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Jalal SI, Panwalkar A, Yang JC, Gubens M, Sequist LV, Awad MM, Fiore J, Ge Y, Raftopoulos H, Gandhi L; KEYNOTE-021 investigators. Langer CJ, et al. Lancet Oncol. 2016 Nov;17(11):1497-1508. doi: 10.1016/S1470-2045(16)30498-3. Epub 2016 Oct 10. Lancet Oncol. 2016. PMID: 27745820 Free PMC article. Clinical Trial.

6

Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer.

Huang CY, Yang YC, Wang KL, Chen TC, Chen JR, Weng CS, Chien HJ, Chang CL. Huang CY, et al. Taiwan J Obstet Gynecol. 2016 Jun;55(3):405-9. doi: 10.1016/j.tjog.2016.04.017. Taiwan J Obstet Gynecol. 2016. PMID: 27343324 Free article.

7

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Effective Predictors of Prognosis in Patients with Acute Mesenteric Arterial Embolism and Thrombosis.

Wang S, Liu H, Wang Q, Cheng Z, Sun S, Zhang Y, Sun X, Wang Z, Ren L. Wang S, et al. Ann Vasc Surg. 2018 May;49:115-122. doi: 10.1016/j.avsg.2018.01.059. Epub 2018 Feb 9. Ann Vasc Surg. 2018. PMID: 29428537

8

Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2^-) Breast Cancer.

Hu Y, Wang S, Ding N, Li N, Huang J, Xiao Z. Hu Y, et al. Clin Breast Cancer. 2020 Aug;20(4):e403-e409. doi: 10.1016/j.clbc.2020.01.008. Epub 2020 Jan 30. Clin Breast Cancer. 2020. PMID: 32201163

9

Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.

Miao Y, Yan Q, Li S, Li B, Feng Y. Miao Y, et al. Cancer Biomark. 2016 Jun 7;17(1):33-40. doi: 10.3233/CBM-160614. Cancer Biomark. 2016. PMID: 27314290

10

Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.

Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert HG, Warkentin TE, Greinacher A. Selleng S, et al. J Thromb Haemost. 2010 Jan;8(1):30-6. doi: 10.1111/j.1538-7836.2009.03626.x. Epub 2009 Sep 28. J Thromb Haemost. 2010. PMID: 19793190 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year